PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Tuberculosis and Respiratory Diseases10.4046/trd.2020.01002020834326-328Recent Advances in Predicting Mortality and Progression of Systemic Sclerosis–Associated Interstitial Lung DiseaseMoo Suk Parkhttp://www.e-trd.org/upload/pdf/trd-2020-0100.pdf, http://www.e-trd.org/journal/view.php?doi=10.4046/trd.2020.0100, http://www.e-trd.org/upload/pdf/trd-2020-0100.pdf
Reactions Weekly10.1007/s40278-021-02013-220211872187-87BCG/cyclophosphamidehttps://link.springer.com/content/pdf/10.1007/s40278-021-02013-2.pdf, https://link.springer.com/article/10.1007/s40278-021-02013-2/fulltext.html, https://link.springer.com/content/pdf/10.1007/s40278-021-02013-2.pdf
Respirology10.1111/resp.14150_976202126S3476-477P16‐67: Kinetic changes of serum KL‐6 levels predict disease progression in systemic sclerosis‐associated interstitial lung diseasehttps://onlinelibrary.wiley.com/doi/pdf/10.1111/resp.14150_976, https://onlinelibrary.wiley.com/doi/full-xml/10.1111/resp.14150_976, https://onlinelibrary.wiley.com/doi/pdf/10.1111/resp.14150_976
Respirology10.1111/resp.13207_456201722257-257RADIOGRAPHIC FIBROSIS SCORE PREDICTS SURVIVAL IN SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASEhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fresp.13207_456, http://onlinelibrary.wiley.com/wol1/doi/10.1111/resp.13207_456/fullpdf
Chest10.1378/chest.15-0003201514851268-1275Predicting Mortality in Systemic Sclerosis-Associated Interstitial Lung Disease Using Risk Prediction Models Derived From Idiopathic Pulmonary FibrosisChristopher J. Ryerson, Darragh O'Connor, James V. Dunne, Fran Schooley, Cameron J. Hague, Darra Murphy, Jonathon Leipsic, Pearce G. Wilcoxhttps://api.elsevier.com/content/article/PII:S0012369215502389?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0012369215502389?httpAccept=text/plain
Therapeutic Advances in Musculoskeletal Disease10.1177/1759720x2110666862022141759720X2110666The role of antifibrotic therapies in the treatment of systemic sclerosis–associated interstitial lung diseaseGonçalo Boleto, Jérôme Avouac, Yannick Allanorehttp://journals.sagepub.com/doi/pdf/10.1177/1759720X211066686, http://journals.sagepub.com/doi/full-xml/10.1177/1759720X211066686, http://journals.sagepub.com/doi/pdf/10.1177/1759720X211066686
Clinical Epidemiology10.2147/clep.s1914182019Volume 11257-273<p>Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease</p>Aurore Bergamasco, Nadine Hartmann, Laura Wallace, Patrice Verpillathttps://www.dovepress.com/getfile.php?fileID=49239, https://www.dovepress.com/getfile.php?fileID=49239
Respiratory Research10.1186/s12931-019-0980-72019201Interstitial lung disease associated with systemic sclerosis (SSc-ILD)Vincent Cottin, Kevin K. Brownhttp://link.springer.com/content/pdf/10.1186/s12931-019-0980-7.pdf, http://link.springer.com/article/10.1186/s12931-019-0980-7/fulltext.html, http://link.springer.com/content/pdf/10.1186/s12931-019-0980-7.pdf
Advances in Therapy10.1007/s12325-022-02078-520223952222-2235Incidence Rate and Prevalence of Systemic Sclerosis and Systemic Sclerosis-Associated Interstitial Lung Disease in Japan: Analysis Using Japanese Claims DatabasesMasataka Kuwana, Aiko Saito, Wataru Sakamoto, Christina Raabe, Kumiko Saitohttps://link.springer.com/content/pdf/10.1007/s12325-022-02078-5.pdf, https://link.springer.com/article/10.1007/s12325-022-02078-5/fulltext.html, https://link.springer.com/content/pdf/10.1007/s12325-022-02078-5.pdf
Therapeutic Advances in Musculoskeletal Disease10.1177/1759720x2110324372021131759720X2110324Interstitial lung disease pathology in systemic sclerosisKristine E. Konopka, Jeffrey L. Myershttp://journals.sagepub.com/doi/pdf/10.1177/1759720X211032437, http://journals.sagepub.com/doi/full-xml/10.1177/1759720X211032437, http://journals.sagepub.com/doi/pdf/10.1177/1759720X211032437